ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #67Top JournalGold OA

Journal of Hematology & Oncology

Abbreviation (ISO):J HEMATOL ONCOL
•
Identifier (ISSN):1756-8722(Print)
•
Publisher:BioMed Central
Clarivate IF (2026)
47.8↑ +7.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Hematology & Oncology

WoS Q1
52443627.3320188.73201911.1202017.4202123.2202228.5202329.5202440.4202547.82026
Annual Impact Factor Metric
Current (2026):47.8
Scopus SJR & RankScopus Q1
11.824
#67

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
194

194 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
143articles/year
100% Gold OA•44.26% Original Research

Aims & Scope

Journal of Hematology & Oncology provides a forum for top-quality research in the fields of hematology and oncology. The journal also publishes reviews and research highlights on "hot topics" from leading experts in the field. Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network (CAHON).

Topics Covered (Recognized by AI)
Biology99%Medicine98.7%Internal medicine95.1%Genetics94.5%Immunology75.6%Chemistry72.4%Biochemistry69.2%Cancer research65.8%Pathology55.3%Cancer53%Gene45.8%Psychology43.2%Psychiatry42%Oncology41.2%Cell biology39.3%Hematology38.2%Surgery31.4%Immune system26.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

HEMATOLOGY

Q1
Rank1/103
IndexSCIE
JCRSCIE2026

ONCOLOGY

Q1
Rank6/333
IndexSCIE
JCISCIE2026

HEMATOLOGY

Q1
Rank1/103
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank9/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF47.8
Articles / Year72
Total Citations134
2025
IF40.4
Articles / Year118
Total Citations3,487
2024
IF29.5
Articles / Year132
Total Citations7,643
2023
IF28.5
Articles / Year123
Total Citations10,086
2022
IF23.168
Articles / Year178
Total Citations22,424

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #67Scopus Q1SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
11.824

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
28.48

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,881 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations12,988
3-Year Documents406
Citable Documents270

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
HematologyQ1
Molecular BiologyQ1
OncologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Hematology & Oncology (abbr: J HEMATOL ONCOL, ISSN: 1756-8722) is a peer-reviewed international scholarly journal in the field of Medicine, published by BioMed Central in England since 2008. The periodical holds a Journal Impact Factor (JIF) of 47.8, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 11.8 (Q1), an H-index of 194.

The journal enforces rigorous peer evaluation with a publication frequency of Irregular, an annual output of approximately 143 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $4,881 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
BioMed Central
Publication Language
English
Frequency
Irregular
Founding Year
2008
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 8f8600ac-c8f9-401b-a017-e3105e6dbf6d
Database Updated: 2026-10-01